HomeAXSM • NASDAQ
add
Axsome Therapeutics Inc
Previous close
$98.19
Day range
$96.79 - $99.30
Year range
$60.28 - $104.98
Market cap
4.74B USD
Avg Volume
503.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 104.76M | 81.27% |
Operating expense | 142.56M | 25.53% |
Net income | -64.60M | -3.86% |
Net profit margin | -61.67 | 42.70% |
Earnings per share | -1.34 | -1.52% |
EBITDA | -43.80M | 27.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 327.34M | -21.42% |
Total assets | 561.46M | -6.56% |
Total liabilities | 468.56M | 41.41% |
Total equity | 92.90M | — |
Shares outstanding | 48.46M | — |
Price to book | 51.14 | — |
Return on assets | -20.83% | — |
Return on capital | -39.87% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -64.60M | -3.86% |
Cash from operations | -18.63M | 65.21% |
Cash from investing | -90.00K | 75.74% |
Cash from financing | 30.40M | -8.89% |
Net change in cash | 11.68M | 156.86% |
Free cash flow | -904.88K | 97.34% |
About
Founded
2012
Website
Employees
607
